<SEC-DOCUMENT>0001628280-19-000571-index.html : 20190128
<SEC-HEADER>0001628280-19-000571.hdr.sgml : 20190128
<ACCEPTANCE-DATETIME>20190125202134
ACCESSION NUMBER:		0001628280-19-000571
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20181116
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190128
DATE AS OF CHANGE:		20190125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		19543679

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>a8kaforvibativfs.htm
<DESCRIPTION>8-K -VIBATIV FINANCIAL STATEMENTS
<TEXT>
Document 1 - file: a8kaforvibativfs.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231.htm
<DESCRIPTION>EXHIBIT 23.1 CONSENT OF INDEPENDANT AUDITORS
<TEXT>
Document 2 - file: exhibit231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1 2017 VIBATIV SPF
<TEXT>
Document 3 - file: exhibit991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>exhibit992.htm
<DESCRIPTION>EXHIBIT 99.2 2018 VIBATIV SPF
<TEXT>
Document 4 - file: exhibit992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>exhibit993.htm
<DESCRIPTION>EXHIBIT 99.3 PROFORM
<TEXT>
Document 5 - file: exhibit993.htm

</DOCUMENT>
</SEC-DOCUMENT>